Economic Observation Network San Nuo Biotechnology has been in a bearish trend in the past 5 days, performing weaker than the market and the industry average. In the past 5 days, the main funds have shown a net outflow overall, with a net proportion much lower than the market average. On May 29th, the main funds showed a net outflow overall, with a balanced net proportion at the market average level. The margin trading difference accounts for 3.82%.
The market attention of this stock is average, and the overall public opinion is neutral. Institutional research is frequent, and the overall research report rating has not changed much. The latest quarterly report disclosed a change of -4.52% in the holding ratio of active equity funds in this stock, and a change of -5.04% in the stock price during the same period. The company has average profitability, average growth ability, excellent operational ability, and weak debt paying ability. The current valuation is in the historical low range and at a relatively high level within the industry. The current price to earnings TTM is 73.79, higher than the industry median, and has been at 68.9% of individual stocks in the past 5 years.
The above content is based on publicly available information and does not constitute investment advice.

In the live broadcast of the 2026 Haier Hope Primary School Children's Day Science and Technology Experience Day, Mei Feng, Chairman of the China Youth Foundation, praised Haier: cooperating with Haier for public welfare can be divided into three levels: public donation, resource linkage, and value co creation. Haier adheres to long termism and a sense of social responsibility, making public welfare projects more in-depth and effective.

CEO of Bangyao Biotechnology responds: has never been subject to regulatory interviews due to BD

Computing power leasing 'grabbing the beach' in 2026